Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01397721 · ClinicalTrials.gov registry record
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 359
- Enrollment target
NCT01397721: Completed study, sponsored by Columbia University.
NCT01397721 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 359 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01397721 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 359 participants
- Enrollment target
Study Summary
The Multi-Ethnic Study of Atherosclerosis (MESA) - Chronic Obstructive Pulmonary Disease (COPD) Study aims to characterize the pulmonary vascular changes and their biology in early COPD using imaging, gene expression profiling and peripheral cellular measures.
Primary Outcome
Cardiac structure: changes in right ventricular (RV) mass, RV mass/Right Ventricular End-Diastolic Volume (RV-EDV) Pulmonary structure: changes in total pulmonary vascular volume (TPVV) and pulmonary artery (PA) perfusion Function: changes in PA flow and distensibility
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 359 participants |
| Start Date | 2009-05 |
| Est. Completion | 2018-04-30 |
What the finished NCT01397721 record still lists
NCT01397721 is an observational study that tracks outcomes without assigning an intervention. The registered 359 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01397721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01397721 about?
NCT01397721 is a clinical study titled "Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary". The Multi-Ethnic Study of Atherosclerosis (MESA) - Chronic Obstructive Pulmonary Disease (COPD) Study aims to characterize the pulmonary vascular changes and their biology in early COPD using imaging, gene expression profiling and peripheral cellular measures.
What is the current status of trial NCT01397721?
This trial is currently completed. The enrollment target is 359 participants. The study started on 2009-05. Estimated completion is 2018-04-30.
Who is sponsoring clinical trial NCT01397721?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05118789 · 359 participants · Phase 1
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia